Company Update (NASDAQ:AMGN): Amgen tops estimates, grows profit 51%

[AAP] – Amgen Inc has boosted its first-quarter profit by 51 per cent, thanks to surging drug sales and ongoing cost cuts designed to free up cash for an unprecedented burst of new . . . → Read More: Company Update (NASDAQ:AMGN): Amgen tops estimates, grows profit 51% Similar Articles: Stock Update (NASDAQ:AMGN): U.S. FDA approves Amgen heart failure drug Stock Update (NASDAQ:AMGN): Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference Company Update (NASDAQ:AMGN): Amgen to appeal rejection of bid to block Novartis biosimilar drug